pipelines

1 Pharma Hoping Its Pipeline Bears Fruit

1 Pharma Hoping Its Pipeline Bears Fruit

The Motley Fool

Pipeline Progress at Synergy Pharma

Pipeline Progress at Synergy Pharma

Yahoo/Zacks

Eli Lilly: Strong Cash Flows And Undervalued Pipeline

Eli Lilly: Strong Cash Flows And Undervalued Pipeline

Seeking Alpha

Merck's Weak Pipeline Will Sink Stock By 2013

Merck's Weak Pipeline Will Sink Stock By 2013

Seeking Alpha

Submitted by moderatorj on Thu, 08/25/2011 - 21:47

Impressive Pipelines From Neoprobe and Ariad

Impressive Pipelines From Neoprobe and Ariad

Yahoo/MarketWire

Street Still Underestimating J&J’s Pipeline: Citi

Street Still Underestimating J&J’s Pipeline: Citi

Barron's

Bristol-Myers Squibb: New Product Potential Outstanding, But Patent Cliff Looms

Bristol-Myers Squibb: New Product Potential Outstanding, But Patent Cliff Looms

Seeking Alpha

Glaxo’s Product Pipeline Needs Priming

Glaxo’s Product Pipeline Needs Priming

WSJ Online

Eli Lilly Plans 10 Drugs in Final-Stage Trials by End of 2011

Eli Lilly Plans 10 Drugs in Final-Stage Trials by End of 2011

Bloomberg

AstraZeneca: Rich Dividend Yield, But Pipeline, Earnings Challenges on the Horizon

AstraZeneca: Rich Dividend Yield, But Pipeline, Earnings Challenges on the Horizon

Seeking Alpha